Browse All

Current Filters

CLEAR FILTER x

TITLE

Post Hoc Analysis of PROGRESS: Evaluating the Safety of Atogepant in Participants With Chronic Migraine and Cardiovascular Risk Factors

Author:Best, Patricia   Harriott, Andrea   Monteith, Teshamae   Tassorelli, Cristina   Nahas, Stephanie   Liu, Yingyi   Dabruzzo, Brett   De Abreu Ferreira, Rosa   Smith, Jonathan H.   

Session Name:P10: Headache: Towards Precision Medicine 1  

Topic:Headache  

Program Number:P10.012  

Author Institution:Mayo Clinic, Rochester, MN  Massachusetts General Hospital, Boston, MA  University of Miami, Miami, FL  University of Pavia, Pavia, Italy  Thomas Jefferson University, Philadelphia, PA  AbbVie, Madison, NJ  AbbVie, Frederick, MD  AbbVie, Canidelo, Portugal  AbbVie, North Chicago, IL  

Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis of the ADVANCE Trial

Author:Nahas, Stephanie   Ailani, Jessica   McAllister, Peter   Halker Singh, Rashmi   Lipton, Richard B.   Ma, Julia   Gandhi, Pranav   Smith, Jonathan H.   Liu, Yingyi   Chalermpalanupap, Natty   Dabruzzo, Brett   

Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

Topic:Headache  

Program Number:P12.001  

Author Institution:Thomas Jefferson University, Philadelphia, PA  Medstar Georgetown Neurology, McLean, VA  New England Inst for Neurology and Headache, Stamford, CT  Mayo Clinic, Scottsdale, AZ  Albert Einstein College of Medicine, Bronx, NY  AbbVie, Madison, NJ  AbbVie, North Chicago, IL  AbbVie , Frederick, MD